Among them, PHF19, AURKA, CHAF1B and AURKB were up-regulated in the tumor group, NAP1L2, TONSL, SATB2 and HDAC9 were down-regulated in the tumor group (Fig. 3D). The gene discussed is NAP1L2; the disease is neoplasm.